3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
25
Recruiting
8
Unknown
2
Terminated
2
Withdrawn
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Colorectal Neoplasms
12
Pancreatic Neoplasms
7
Nasopharyngeal Carcinoma
5
Cholangiocarcinoma
5
Biliary Tract Neoplasms
4
Rectal Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Colonic Neoplasms
3
Cirrhosis, Familial, with Pulmonary Hypertension
3
Stomach Neoplasms
2
Neoplasm Metastasis
2
Esophageal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Neuroendocrine
2
Urinary Bladder Neoplasms
1
Rare Tumour
1
Pathologic Complete Response
1
Pancreatic Cancer Resectable
1
PDAC - Pancreatic Ductal Adenocarcinoma
1
Neoplasms, Second Primary
1
Neoplasms
1
Neoplasm, Residual
1
Neoadjuvant Chemotherapy
1
Muscle Neoplasms
1
Locally Advanced Low Rectal Adenocarcinoma
1
Liver Neoplasms
1
Liver Metastases of Colorectal Cancer
1
Keratosis, Actinic
1
HER2-positive Gastric Cancer
1
Gastroesophageal Junction Cancer
1
Interventions
Oxaliplatin
4
Capecitabine
3
Radiotherapy
2
Docetaxel
2
Androgen Antagonists
2
tislelizumab
1
pembrolizumab
1
luprolide acetate gel depot
1
lenvatinib
1
enzalutamide
1
cemiplimab
1
Surgical Procedures, Operative
1
Radiotherapy, Image-Guided
1
Poly(ADP-ribose) Polymerase Inhibitors
1
PF06821497
1
Negative-Pressure Wound Therapy
1
Leuprolide
1
Leucovorin
1
Injections
1
Fluorouracil
1
Drug Therapy
1
ALT-803
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Adenocarcinoma
×
Fluorouracil
×
Clear all
NCT07118800
2025-08-12
NACRE-2
UNICANCER
Phase 3
Not yet recruiting
160 enrolled